Skip to content
Screener

Turn Therapeutics Inc. TTRX Q1 2026 Annual earnings

Reported May 11, 2026 · Before market open

EPS-$0.03Miss by $0.01
EPS estimate-$0.02

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.09

Financials

Q1 2026

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M—
Total equity$6.1M+647%
Total assets$18.6M—

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$94.22M—
Enterprise value$89.01M—

Returns & leverage

See full
Debt / equity1×—
Current ratio2.2×—

Versus estimates

Diluted EPS

Q2 2026-$0.20Miss by $0.18
Q1 2026-$0.03Miss by $0.01
Q4 2025-$0.09Miss by $0.04Q3 2025-$0.07

FAQ

When did Turn Therapeutics Inc. report Q1 2026 earnings?
Turn Therapeutics Inc. (TTRX) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Turn Therapeutics Inc.'s Q1 2026 revenue and EPS?
Turn Therapeutics Inc. reported eps of $-0.03 for Q1 2026.
Did Turn Therapeutics Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.02 by $0.01.
Where can I find Turn Therapeutics Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-054480) and the 10-K periodic report (0001213900-26-037505) directly on SEC EDGAR. The filing index links above go to sec.gov.